Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium channel activity	PKD1L1 PKD1L3 RYR1 RYR3 ITPR3 ORAI1 CNGA3	5.69e-05	129	151	7	GO:0005262
GeneOntologyMolecularFunction	intracellularly ligand-gated monoatomic ion channel activity	RYR1 RYR3 ITPR3 CNGA3	1.08e-04	33	151	4	GO:0005217
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	PKD1L1 PKD1L3 RYR1 RYR3 ITPR3 ORAI1 CNGA3	1.53e-04	151	151	7	GO:0015085
GeneOntologyMolecularFunction	monoatomic cation channel activity	PKD1L1 ABCC9 PKD1L3 CHRNA4 RYR1 RYR3 ITPR3 ORAI1 CNGA3 UNC80	2.89e-04	343	151	10	GO:0005261
GeneOntologyMolecularFunction	intracellularly gated calcium channel activity	RYR1 RYR3 ITPR3	3.18e-04	18	151	3	GO:0015278
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR3	3.37e-04	4	151	2	GO:0005219
GeneOntologyMolecularFunction	cytoskeletal protein binding	HAUS6 BIN1 NRAP MYO1A EML4 KIF1B ENC1 CAPZB NEB NF1 PTPRN CEP135 CEP70 KIF28P MACF1 MTCL1 DMD GNB3 CNGA3	6.44e-04	1099	151	19	GO:0008092
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity	ABCC9 CHRNA4 RYR1 RYR3 ITPR3 CNGA3 GABRR3	6.76e-04	193	151	7	GO:0015276
GeneOntologyMolecularFunction	ligand-gated monoatomic cation channel activity	ABCC9 CHRNA4 RYR1 RYR3 ITPR3 CNGA3	6.91e-04	140	151	6	GO:0099094
GeneOntologyMolecularFunction	monoatomic ion channel activity	PKD1L1 ABCC9 PKD1L3 CHRNA4 RYR1 RYR3 ITPR3 ORAI1 CNGA3 UNC80 GABRR3	7.54e-04	459	151	11	GO:0005216
GeneOntologyMolecularFunction	ligand-gated channel activity	ABCC9 CHRNA4 RYR1 RYR3 ITPR3 CNGA3 GABRR3	7.63e-04	197	151	7	GO:0022834
GeneOntologyMolecularFunction	ATP-dependent activity	DNHD1 ABCA2 MYO1A ABCA13 KIF1B ABCC9 ORC1 MDN1 FBH1 ATP6V0A4 KIF28P MACF1 DYNC1H1	8.03e-04	614	151	13	GO:0140657
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR1 RYR3	8.35e-04	6	151	2	GO:0048763
GeneOntologyMolecularFunction	retinoic acid binding	UGT2B7 UGT2B15 UGT2B17	1.21e-03	28	151	3	GO:0001972
GeneOntologyCellularComponent	somatodendritic compartment	ZC3H14 RELN BIN1 MYO1A COPA DLGAP4 KIF1B ENC1 CAPZB NCAM1 RET NR3C1 CHRM2 CHRNA4 ITPR3 NF1 RACK1 SACS PTPRN WASHC5 DMD GNB3 CNGA3 DYNC1H1	1.12e-05	1228	154	24	GO:0036477
GeneOntologyCellularComponent	axon	ATG5 ZC3H14 TSHZ3 RELN BIN1 MYO1A COPA KIF1B NCAM1 RET CHRM2 ORAI1 NF1 SACS PTPRN DMD CNGA3 DYNC1H1 UNC80	3.15e-05	891	154	19	GO:0030424
GeneOntologyCellularComponent	cell body	RELN MYO1A COPA DLGAP4 ENC1 CAPZB NCAM1 RET CHRM2 GFAP CHRNA4 ITPR3 RACK1 PTPRN WASHC5 DMD GNB3 CNGA3 DYNC1H1	5.52e-05	929	154	19	GO:0044297
GeneOntologyCellularComponent	transmembrane transporter complex	ABCA2 PKD1L1 ABCC9 PKD1L3 CHRNA4 RYR1 RYR3 ORAI1 SLC9A1 ATP6V0A4 CNGA3 UNC80 GABRR3	1.37e-04	523	154	13	GO:1902495
GeneOntologyCellularComponent	neuronal cell body	RELN MYO1A COPA DLGAP4 ENC1 CAPZB NCAM1 RET CHRM2 CHRNA4 ITPR3 RACK1 PTPRN WASHC5 DMD CNGA3 DYNC1H1	1.47e-04	835	154	17	GO:0043025
GeneOntologyCellularComponent	WASH complex	WASHC4 CAPZB WASHC5	1.67e-04	15	154	3	GO:0071203
GeneOntologyCellularComponent	nuclear outer membrane	ITPR3 UGT2B7 UGT2B15 UGT2B17	2.11e-04	40	154	4	GO:0005640
GeneOntologyCellularComponent	transporter complex	ABCA2 PKD1L1 ABCC9 PKD1L3 CHRNA4 RYR1 RYR3 ORAI1 SLC9A1 ATP6V0A4 CNGA3 UNC80 GABRR3	2.24e-04	550	154	13	GO:1990351
GeneOntologyCellularComponent	organelle outer membrane	BCL2L2 MLXIP CPT1A ITPR3 UGT2B7 UGT2B15 UGT2B17 DMD IMMT	2.32e-04	279	154	9	GO:0031968
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	ATG5 MRC1 IL15RA BIN1 ABCA2 WASHC4 COPA DSP ABCA13 PLEKHF2 KIF1B RET CHRM2 ITPR3 PTPRN WASHC5 CADPS ATP6V0A4 RAB15 ADGRE5 DMD ULK2	2.39e-04	1307	154	22	GO:0030659
GeneOntologyCellularComponent	outer membrane	BCL2L2 MLXIP CPT1A ITPR3 UGT2B7 UGT2B15 UGT2B17 DMD IMMT	2.44e-04	281	154	9	GO:0019867
GeneOntologyCellularComponent	vesicle membrane	ATG5 MRC1 IL15RA BIN1 ABCA2 WASHC4 COPA DSP ABCA13 PLEKHF2 KIF1B RET CHRM2 ITPR3 PTPRN WASHC5 CADPS ATP6V0A4 RAB15 ADGRE5 DMD ULK2	2.89e-04	1325	154	22	GO:0012506
GeneOntologyCellularComponent	cation channel complex	PKD1L1 ABCC9 PKD1L3 RYR1 RYR3 ORAI1 CNGA3 UNC80	3.62e-04	235	154	8	GO:0034703
GeneOntologyCellularComponent	monoatomic ion channel complex	PKD1L1 ABCC9 PKD1L3 CHRNA4 RYR1 RYR3 ORAI1 CNGA3 UNC80 GABRR3	5.08e-04	378	154	10	GO:0034702
GeneOntologyCellularComponent	sarcomere	BIN1 NRAP CAPZB ABCC9 NEB RYR1 RYR3 DMD	5.31e-04	249	154	8	GO:0030017
GeneOntologyCellularComponent	cholinergic synapse	DLGAP4 CHRM2 CHRNA4	5.45e-04	22	154	3	GO:0098981
GeneOntologyCellularComponent	dendrite	ZC3H14 RELN BIN1 DLGAP4 KIF1B CAPZB RET NR3C1 CHRM2 CHRNA4 ITPR3 NF1 RACK1 SACS GNB3 CNGA3	6.09e-04	858	154	16	GO:0030425
GeneOntologyCellularComponent	dendritic tree	ZC3H14 RELN BIN1 DLGAP4 KIF1B CAPZB RET NR3C1 CHRM2 CHRNA4 ITPR3 NF1 RACK1 SACS GNB3 CNGA3	6.24e-04	860	154	16	GO:0097447
GeneOntologyCellularComponent	ATPase dependent transmembrane transport complex	ABCA2 ABCC9 SLC9A1 ATP6V0A4	7.21e-04	55	154	4	GO:0098533
GeneOntologyCellularComponent	Z disc	BIN1 NRAP NEB RYR1 RYR3 DMD	8.98e-04	151	154	6	GO:0030018
GeneOntologyCellularComponent	myofibril	BIN1 NRAP CAPZB ABCC9 NEB RYR1 RYR3 DMD	9.65e-04	273	154	8	GO:0030016
GeneOntologyCellularComponent	supramolecular fiber	HAUS6 BIN1 NRAP MYO1A DSP EML4 KIF1B CAPZB ABCC9 NEB GFAP RYR1 RYR3 KRT23 KIF28P MACF1 MTCL1 DMD DYNC1H1	1.10e-03	1179	154	19	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	HAUS6 BIN1 NRAP MYO1A DSP EML4 KIF1B CAPZB ABCC9 NEB GFAP RYR1 RYR3 KRT23 KIF28P MACF1 MTCL1 DMD DYNC1H1	1.19e-03	1187	154	19	GO:0099081
GeneOntologyCellularComponent	contractile muscle fiber	BIN1 NRAP CAPZB ABCC9 NEB RYR1 RYR3 DMD	1.42e-03	290	154	8	GO:0043292
GeneOntologyCellularComponent	I band	BIN1 NRAP NEB RYR1 RYR3 DMD	1.46e-03	166	154	6	GO:0031674
GeneOntologyCellularComponent	preribosome	RIOK3 MDN1 PWP2 PDCD11 RIOK2	1.57e-03	114	154	5	GO:0030684
GeneOntologyCellularComponent	cytoplasmic side of membrane	DIABLO GFAP RYR1 RYR3 ITPR3 GNB3 EFCAB7	1.61e-03	230	154	7	GO:0098562
GeneOntologyCellularComponent	junctional membrane complex	RYR1 RYR3	1.88e-03	9	154	2	GO:0030314
GeneOntologyCellularComponent	calcium channel complex	PKD1L1 RYR1 RYR3 ORAI1	2.08e-03	73	154	4	GO:0034704
GeneOntologyCellularComponent	NLS-dependent protein nuclear import complex	MYBBP1A SNUPN	2.33e-03	10	154	2	GO:0042564
GeneOntologyCellularComponent	T-tubule	BIN1 ABCC9 RYR1 SLC9A1	2.77e-03	79	154	4	GO:0030315
GeneOntologyCellularComponent	sarcolemma	BIN1 ABCC9 RYR1 RYR3 SLC9A1 DMD	2.88e-03	190	154	6	GO:0042383
GeneOntologyCellularComponent	nucleocytoplasmic transport complex	MYBBP1A SNUPN	3.39e-03	12	154	2	GO:0031074
HumanPheno	Pes cavus	TRAPPC11 BIN1 SPEG KIF1B CARS1 NARS1 RET NEB RYR1 ITPR3 NF1 SACS WASHC5 MAFB DYNC1H1	1.12e-06	304	59	15	HP:0001761
HumanPheno	Abnormal calf musculature morphology	TRAPPC11 BIN1 NEB RYR1 SACS WASHC5 DMD	1.45e-05	71	59	7	HP:0001430
HumanPheno	Gowers sign	TRAPPC11 BIN1 SPEG RYR1 RYR3 ORAI1 DMD	2.71e-05	78	59	7	HP:0003391
MousePheno	neonatal lethality, complete penetrance	ATG5 TSHZ3 BIN1 KIF1B RET NR3C1 CHRNA4 RYR1 ORAI1 CADPS CEP135 PRDM12 MAFB MAPK6 DYNC1H1 UNC80	1.77e-05	534	123	16	MP:0011087
MousePheno	abnormal Sertoli cell barrier morphology	BCL2L2 ORAI1 NF1	2.27e-05	7	123	3	MP:0020355
Domain	RIH_assoc-dom	RYR1 RYR3 ITPR3	9.98e-06	6	150	3	IPR013662
Domain	Ins145_P3_rec	RYR1 RYR3 ITPR3	9.98e-06	6	150	3	PF08709
Domain	RIH_assoc	RYR1 RYR3 ITPR3	9.98e-06	6	150	3	PF08454
Domain	RIH_dom	RYR1 RYR3 ITPR3	9.98e-06	6	150	3	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR3 ITPR3	9.98e-06	6	150	3	IPR014821
Domain	Ryanodine_recept-rel	RYR1 RYR3 ITPR3	9.98e-06	6	150	3	IPR015925
Domain	-	RYR1 RYR3 ITPR3	9.98e-06	6	150	3	1.25.10.30
Domain	RYDR_ITPR	RYR1 RYR3 ITPR3	9.98e-06	6	150	3	PF01365
Domain	MIR	RYR1 RYR3 ITPR3	5.85e-05	10	150	3	PF02815
Domain	MIR_motif	RYR1 RYR3 ITPR3	5.85e-05	10	150	3	IPR016093
Domain	MIR	RYR1 RYR3 ITPR3	5.85e-05	10	150	3	PS50919
Domain	MIR	RYR1 RYR3 ITPR3	5.85e-05	10	150	3	SM00472
Domain	Teashirt_fam	TSHZ3 TSHZ2	1.91e-04	3	150	2	IPR027008
Domain	Ryanodine_rcpt	RYR1 RYR3	1.91e-04	3	150	2	IPR003032
Domain	RIO_kinase_CS	RIOK3 RIOK2	1.91e-04	3	150	2	IPR018935
Domain	Ryanrecept_TM4-6	RYR1 RYR3	1.91e-04	3	150	2	IPR009460
Domain	RyR	RYR1 RYR3	1.91e-04	3	150	2	PF02026
Domain	tRNA_intron_Endonuc_cat-like	TSEN2 TSEN15	1.91e-04	3	150	2	IPR006677
Domain	RIO	RIOK3 RIOK2	1.91e-04	3	150	2	SM00090
Domain	RR_TM4-6	RYR1 RYR3	1.91e-04	3	150	2	PF06459
Domain	RIO1	RIOK3 RIOK2	1.91e-04	3	150	2	PS01245
Domain	Ryan_recept	RYR1 RYR3	1.91e-04	3	150	2	IPR013333
Domain	LH2	PKD1L1 PKD1L3 LOXHD1	3.79e-04	18	150	3	SM00308
Domain	Nebulin	NRAP NEB	3.80e-04	4	150	2	PF00880
Domain	NEBULIN	NRAP NEB	3.80e-04	4	150	2	PS51216
Domain	NEBU	NRAP NEB	3.80e-04	4	150	2	SM00227
Domain	Nebulin	NRAP NEB	3.80e-04	4	150	2	IPR013998
Domain	RIO_kinase	RIOK3 RIOK2	3.80e-04	4	150	2	IPR000687
Domain	Nebulin_repeat	NRAP NEB	3.80e-04	4	150	2	IPR000900
Domain	-	PKD1L1 PKD1L3 LOXHD1	6.07e-04	21	150	3	2.60.60.20
Domain	UDPGT	UGT2B7 UGT2B15 UGT2B17	6.07e-04	21	150	3	PF00201
Domain	PLAT	PKD1L1 PKD1L3 LOXHD1	6.07e-04	21	150	3	PF01477
Domain	PLAT/LH2_dom	PKD1L1 PKD1L3 LOXHD1	6.07e-04	21	150	3	IPR001024
Domain	PLAT	PKD1L1 PKD1L3 LOXHD1	6.07e-04	21	150	3	PS50095
Domain	UDPGT	UGT2B7 UGT2B15 UGT2B17	6.07e-04	21	150	3	PS00375
Domain	UDP_glucos_trans	UGT2B7 UGT2B15 UGT2B17	6.07e-04	21	150	3	IPR002213
Domain	-	DSP MACF1	9.41e-04	6	150	2	3.90.1290.10
Domain	AAA	ABCA2 ABCA13 ABCC9 ORC1 MDN1 DYNC1H1	1.09e-03	144	150	6	SM00382
Domain	AAA+_ATPase	ABCA2 ABCA13 ABCC9 ORC1 MDN1 DYNC1H1	1.09e-03	144	150	6	IPR003593
Domain	Plectin	DSP MACF1	1.31e-03	7	150	2	PF00681
Domain	Plectin_repeat	DSP MACF1	1.31e-03	7	150	2	IPR001101
Domain	PLEC	DSP MACF1	1.31e-03	7	150	2	SM00250
Domain	Kinase-like_dom	SPEG RIOK3 RET MELK TNNI3K IKBKE BTK MACF1 DMD MAPK6 RIOK2 ULK2	1.45e-03	542	150	12	IPR011009
Domain	Spectrin_repeat	DSP MACF1 DMD	1.59e-03	29	150	3	IPR002017
Domain	HATC_C_dom	ZBED6 ZMYM1	1.74e-03	8	150	2	IPR008906
Domain	Dimer_Tnp_hAT	ZBED6 ZMYM1	1.74e-03	8	150	2	PF05699
Domain	WD40_repeat_CS	COPA EML4 NWD2 RACK1 PWP2 GNB3	2.11e-03	164	150	6	IPR019775
Domain	SPEC	DSP MACF1 DMD	2.12e-03	32	150	3	SM00150
Domain	Spectrin/alpha-actinin	DSP MACF1 DMD	2.12e-03	32	150	3	IPR018159
Domain	GPS	PKD1L1 PKD1L3 ADGRE5	2.99e-03	36	150	3	PS50221
Domain	GPS	PKD1L1 PKD1L3 ADGRE5	3.23e-03	37	150	3	IPR000203
Domain	Rap_GAP_dom	RALGAPB RALGAPA2	3.36e-03	11	150	2	IPR000331
Domain	RAPGAP	RALGAPB RALGAPA2	3.36e-03	11	150	2	PS50085
Domain	PKD_channel	PKD1L1 PKD1L3	3.36e-03	11	150	2	PF08016
Domain	PKD1_2_channel	PKD1L1 PKD1L3	3.36e-03	11	150	2	IPR013122
Domain	ABC_A	ABCA2 ABCA13	4.01e-03	12	150	2	IPR026082
Domain	G-protein_beta_WD-40_rep	COPA RACK1 PWP2 GNB3	4.89e-03	85	150	4	IPR020472
Domain	-	RYR1 RYR3 RASGRP3 USP32 MACF1 DMD EFCAB7	5.20e-03	261	150	7	1.10.238.10
Domain	Dynein_HC_stalk	DNHD1 DYNC1H1	5.47e-03	14	150	2	IPR024743
Domain	Dynein_heavy_dom-2	DNHD1 DYNC1H1	5.47e-03	14	150	2	IPR013602
Domain	DHC_N2	DNHD1 DYNC1H1	5.47e-03	14	150	2	PF08393
Domain	ATPase_dyneun-rel_AAA	MDN1 DYNC1H1	5.47e-03	14	150	2	IPR011704
Domain	MT	DNHD1 DYNC1H1	5.47e-03	14	150	2	PF12777
Domain	AAA_5	MDN1 DYNC1H1	5.47e-03	14	150	2	PF07728
Domain	WD40	COPA EML4 PPP2R2C NWD2 RACK1 PWP2 GNB3	5.99e-03	268	150	7	SM00320
Domain	Prot_kinase_dom	SPEG RIOK3 RET MELK TNNI3K IKBKE BTK MAPK6 RIOK2 ULK2	6.20e-03	489	150	10	IPR000719
Domain	DHC_fam	DNHD1 DYNC1H1	6.28e-03	15	150	2	IPR026983
Domain	Dynein_heavy	DNHD1 DYNC1H1	6.28e-03	15	150	2	PF03028
Domain	Dynein_heavy_dom	DNHD1 DYNC1H1	6.28e-03	15	150	2	IPR004273
Domain	WD40_repeat	COPA EML4 PPP2R2C NWD2 RACK1 PWP2 GNB3	6.48e-03	272	150	7	IPR001680
Domain	PROTEIN_KINASE_DOM	SPEG RIOK3 RET MELK TNNI3K IKBKE BTK MAPK6 RIOK2 ULK2	6.56e-03	493	150	10	PS50011
Domain	ABC_tran	ABCA2 ABCA13 ABCC9	6.74e-03	48	150	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCA2 ABCA13 ABCC9	6.74e-03	48	150	3	PS50893
Domain	ABC_TRANSPORTER_1	ABCA2 ABCA13 ABCC9	7.14e-03	49	150	3	PS00211
Domain	PH	DOK6 PLEKHF2 KIF1B ARHGEF18 ARHGEF39 CADPS BTK	7.27e-03	278	150	7	SM00233
Domain	WD_REPEATS_1	COPA EML4 PPP2R2C NWD2 RACK1 PWP2 GNB3	7.27e-03	278	150	7	PS00678
Domain	WD_REPEATS_2	COPA EML4 PPP2R2C NWD2 RACK1 PWP2 GNB3	7.41e-03	279	150	7	PS50082
Domain	WD_REPEATS_REGION	COPA EML4 PPP2R2C NWD2 RACK1 PWP2 GNB3	7.41e-03	279	150	7	PS50294
Domain	PH_DOMAIN	DOK6 PLEKHF2 KIF1B ARHGEF18 ARHGEF39 CADPS BTK	7.41e-03	279	150	7	PS50003
Domain	PH_domain	DOK6 PLEKHF2 KIF1B ARHGEF18 ARHGEF39 CADPS BTK	7.55e-03	280	150	7	IPR001849
Domain	ABC_transporter-like	ABCA2 ABCA13 ABCC9	7.55e-03	50	150	3	IPR003439
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ATG5 RELN BIN1 ABCA2 WASHC4 COPA DSP KIF1B ENC1 NARS1 UBASH3A GFAP RYR3 MIPOL1 PPP2R5E FBH1 SACS SBNO1 CADPS USP32 CEP70 MACF1 IMMT DYNC1H1	2.64e-09	1285	154	24	35914814
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYBBP1A BIN1 COPA DSP DLGAP4 KIF1B CAPZB NARS1 NCAM1 GFAP PPP2R2C NWD2 PPP2R5E NF1 RACK1 SACS WASHC5 CADPS NUFIP2 MACF1 DMD GNB3 IMMT DYNC1H1	2.08e-08	1431	154	24	37142655
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ATG5 MYBBP1A WASHC4 COPA DSP EML4 CAPZB NARS1 RIOK3 ACTL6A MELK ORC1 GTF2H1 NF1 MDN1 RACK1 WASHC5 PDCD11 MACF1 CDC27 RIOK2 IMMT DYNC1H1	3.32e-08	1353	154	23	29467282
Pubmed	Tissue distribution and relative gene expression of UDP-glucuronosyltransferases (2B7, 2B15, 2B17) in the human fetus.	UGT2B7 UGT2B15 UGT2B17	8.51e-08	3	154	3	23223495
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	WASHC4 COPA DSP NEB GFAP ITPR3 RACK1 USP32 MACF1 DMD DYNC1H1	2.24e-07	322	154	11	26514267
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ZC3H14 MYBBP1A COPA DSP NARS1 ITPR3 NF1 MDN1 RACK1 NUFIP2 PWP2 PDCD11 MACF1 IMMT DYNC1H1	2.41e-07	653	154	15	22586326
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SPEG DLGAP4 KIF1B RALGAPB MLXIP PPP2R5E CADPS NUFIP2 MACF1 MTCL1 ULK2 DYNC1H1	3.02e-07	407	154	12	12693553
Pubmed	Characterization of the binding sites for the interactions between FKBP12 and intracellular calcium release channels.	RYR1 RYR3 ITPR3	3.39e-07	4	154	3	22100703
Pubmed	Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.	UGT2B7 UGT2B15 UGT2B17	3.39e-07	4	154	3	26176234
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	HAUS6 MYBBP1A COPA DSP KIF1B CAPZB NARS1 ANKRD50 RACK1 NUFIP2 C1QBP MACF1 CDC27 IMMT DYNC1H1	6.66e-07	708	154	15	39231216
Pubmed	Membrane depolarization causes a direct activation of G protein-coupled receptors leading to local Ca2+ release in smooth muscle.	CHRM2 RYR1 RYR3	1.69e-06	6	154	3	19549818
Pubmed	Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.	RYR1 RYR3 ITPR3	1.69e-06	6	154	3	25966694
Pubmed	A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells.	RYR1 RYR3 ITPR3	1.69e-06	6	154	3	20519450
Pubmed	Roles of I(f) and intracellular Ca2+ release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development.	RYR1 RYR3 ITPR3	1.69e-06	6	154	3	23463619
Pubmed	IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1.	RYR1 RYR3 ITPR3	1.69e-06	6	154	3	16844763
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	HAUS6 MYBBP1A DIABLO EML4 KIF1B CAPZB BBS9 MELK MIPOL1 GTF2H1 PPP2R5E NF1 CNOT6L SBNO1 NUFIP2 C3 TFB2M CDC27 IMMT DYNC1H1	1.71e-06	1321	154	20	27173435
Pubmed	Developmental expression of the calcium release channels during early neurogenesis of the mouse cerebral cortex.	RYR1 RYR3 ITPR3	2.94e-06	7	154	3	11860456
Pubmed	Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.	UGT2B7 UGT2B15 UGT2B17	2.94e-06	7	154	3	26074487
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	ATG5 ZC3H14 MYBBP1A COPA EML4 CARS1 NARS1 ACTL6A NR3C1 CPT1A ITPR3 RACK1 NUFIP2 IMMT	3.16e-06	701	154	14	30196744
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ZC3H14 MYBBP1A COPA DSP CAPZB NARS1 ACTL6A ITPR3 GTF2H1 RACK1 NUFIP2 PWP2 C1QBP PDCD11 C3 RAB15 TFB2M IMMT DYNC1H1	3.25e-06	1257	154	19	36526897
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	HAUS6 MYBBP1A WASHC4 COPA ACTL6A TSEN2 ORC1 PPP2R5E CNOT6L RACK1 WASHC5 CEP135 C1QBP ZMYM1 MTCL1 CDC27 TSEN15 DYNC1H1	3.96e-06	1155	154	18	20360068
Pubmed	Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.	UGT2B7 UGT2B15 UGT2B17	4.69e-06	8	154	3	32093886
Pubmed	Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry.	UGT2B7 UGT2B15 UGT2B17	4.69e-06	8	154	3	22579593
Pubmed	ORAI1, STIM1/2, and RYR1 shape subsecond Ca2+ microdomains upon T cell activation.	RYR1 RYR3 ORAI1	4.69e-06	8	154	3	30563862
Pubmed	Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States.	UGT2B7 UGT2B15 UGT2B17	4.69e-06	8	154	3	20142249
Pubmed	Cytoarchitecture of the olfactory bulb in the laggard mutant mouse.	RELN NCAM1 GFAP	4.69e-06	8	154	3	24931760
Pubmed	The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.	UGT2B7 UGT2B15 UGT2B17	4.69e-06	8	154	3	18719240
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	RYR1 RYR3 ITPR3	4.69e-06	8	154	3	19033399
Pubmed	Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy.	TRAPPC11 MYBBP1A WASHC4 RALGAPB CAPZB CARS1 ACTL6A AZI2 NF1 RACK1 PWP2	6.27e-06	454	154	11	33226137
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	WWC3 RALGAPB ANKRD50 RALGAPA2 NWD2 MACF1	6.86e-06	103	154	6	10574462
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	ATG5 BIN1 GNPDA1 WASHC4 COPA DIABLO KIF1B CAPZB CARS1 NARS1 NR3C1 TSEN2 PPP2R5E RACK1 SBNO1 WASHC5 C1QBP MACF1 PSMD14 DYNC1H1	7.23e-06	1455	154	20	22863883
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	DNHD1 MYBBP1A DIABLO DSP NEB MDN1 MACF1 DMD	1.05e-05	234	154	8	36243803
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	MYBBP1A COPA DSP SNUPN MELK NF1 MDN1 MACF1 MTCL1 GNB3 CDC27 DYNC1H1	1.20e-05	582	154	12	20467437
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HAUS6 GNPDA1 TBC1D30 ARHGEF18 BCL2L2 RALGAPA2 SACS RASGRP3 CEP135 MACF1 UNC80	1.35e-05	493	154	11	15368895
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ZC3H14 MYBBP1A COPA DSP CAPZB ITPR3 NF1 MDN1 RACK1 SACS PWP2 C1QBP PDCD11 MACF1 IMMT DYNC1H1	1.36e-05	1024	154	16	24711643
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	BIN1 NRAP DSP KIF1B RIOK3 ANKRD50 NEB RYR1 PPP2R5E RACK1 MACF1	1.46e-05	497	154	11	23414517
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	BIN1 CEP135 MACF1 DMD IMMT DYNC1H1	1.65e-05	120	154	6	31413325
Pubmed	The Arp2/3 activator WASH controls the fission of endosomes through a large multiprotein complex.	WASHC4 CAPZB WASHC5	1.82e-05	12	154	3	19922875
Pubmed	Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.	UGT2B7 UGT2B15 UGT2B17	1.82e-05	12	154	3	20308471
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	MYBBP1A COPA DSP EML4 NARS1 ITPR3 RACK1 PDCD11 MACF1 C3 PSMD14 IMMT DYNC1H1	1.83e-05	711	154	13	33022573
Pubmed	RACK1 Is an Interaction Partner of ATG5 and a Novel Regulator of Autophagy.	ATG5 RACK1	1.95e-05	2	154	2	27325703
Pubmed	Orai1 mediates exacerbated Ca(2+) entry in dystrophic skeletal muscle.	ORAI1 DMD	1.95e-05	2	154	2	23185465
Pubmed	Contractile impairment and structural alterations of skeletal muscles from knockout mice lacking type 1 and type 3 ryanodine receptors.	RYR1 RYR3	1.95e-05	2	154	2	9489997
Pubmed	Identification and validation of the microRNA response elements in the 3'-untranslated region of the UDP glucuronosyltransferase (UGT) 2B7 and 2B15 genes by a functional genomics approach.	UGT2B7 UGT2B15	1.95e-05	2	154	2	28962835
Pubmed	The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence.	UGT2B15 UGT2B17	1.95e-05	2	154	2	1909870
Pubmed	A regulatory subunit of protein phosphatase 2A, PPP2R5E, regulates the abundance of microtubule crosslinking factor 1.	PPP2R5E MTCL1	1.95e-05	2	154	2	27521566
Pubmed	UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.	UGT2B15 UGT2B17	1.95e-05	2	154	2	17848572
Pubmed	Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.	UGT2B15 UGT2B17	1.95e-05	2	154	2	27496708
Pubmed	Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development.	RYR1 RYR3	1.95e-05	2	154	2	17118445
Pubmed	The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.	UGT2B15 UGT2B17	1.95e-05	2	154	2	17698910
Pubmed	Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes.	RET NF1	1.95e-05	2	154	2	24361808
Pubmed	Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene.	RYR1 RYR3	1.95e-05	2	154	2	12565913
Pubmed	Functional and morphological features of skeletal muscle from mutant mice lacking both type 1 and type 3 ryanodine receptors.	RYR1 RYR3	1.95e-05	2	154	2	9192302
Pubmed	Glial cell line-derived neurotrophic factor (GDNF) induces neuritogenesis in the cochlear spiral ganglion via neural cell adhesion molecule (NCAM).	NCAM1 RET	1.95e-05	2	154	2	23262364
Pubmed	Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects.	UGT2B7 UGT2B15	1.95e-05	2	154	2	17687269
Pubmed	Isolation and partial cloning of ryanodine-sensitive Ca2+ release channel protein isoforms from human myometrial smooth muscle.	RYR1 RYR3	1.95e-05	2	154	2	7556644
Pubmed	Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers.	TSHZ3 TSHZ2	1.95e-05	2	154	2	21423795
Pubmed	Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation.	UGT2B15 UGT2B17	1.95e-05	2	154	2	3117546
Pubmed	Genetic mapping of the locus controlling structural variations of murine C3 in the chromosome 17.	ITPR3 C3	1.95e-05	2	154	2	458159
Pubmed	Lethal multiple pterygium syndrome, large cystic hygroma, and cleft palate: Rare and severe fetal presentations of RYR1- and NEB-related congenital myopathies.	NEB RYR1	1.95e-05	2	154	2	38520674
Pubmed	Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells.	UGT2B15 UGT2B17	1.95e-05	2	154	2	32660355
Pubmed	Neurofibromin interacts with the cytoplasmic Dynein Heavy Chain 1 in melanosomes of human melanocytes.	NF1 DYNC1H1	1.95e-05	2	154	2	23583712
Pubmed	The block of ryanodine receptors selectively inhibits fetal myoblast differentiation.	RYR1 RYR3	1.95e-05	2	154	2	12640042
Pubmed	Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.	UGT2B15 UGT2B17	1.95e-05	2	154	2	24121496
Pubmed	Possible involvement of ryanodine receptor-mediated intracellular calcium release in the effect of corticotropin-releasing factor on adrenocorticotropin secretion.	RYR1 RYR3	1.95e-05	2	154	2	14592949
Pubmed	Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.	UGT2B15 UGT2B17	1.95e-05	2	154	2	24267955
Pubmed	Adipocytes contain a novel complex similar to the tuberous sclerosis complex.	RALGAPB RALGAPA2	1.95e-05	2	154	2	16490346
Pubmed	Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.	UGT2B15 UGT2B17	1.95e-05	2	154	2	22170718
Pubmed	The glucocorticoid receptor acts locally to protect dystrophic muscle and heart during disease.	NR3C1 DMD	1.95e-05	2	154	2	38770680
Pubmed	Morphological abnormalities of adrenal gland and hypertrophy of liver in mutant mice lacking ryanodine receptors.	RYR1 RYR3	1.95e-05	2	154	2	9799464
Pubmed	Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5.	UGT2B15 UGT2B17	1.95e-05	2	154	2	3105095
Pubmed	RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle.	RYR1 RYR3	1.95e-05	2	154	2	11500519
Pubmed	Expression of NCAM and its polysialylated isoforms during mdx mouse muscle regeneration and in vitro myogenesis.	NCAM1 DMD	1.95e-05	2	154	2	7919966
Pubmed	Circulating CD56+ NKG2D+ NK cells and postoperative fertility in ovarian endometrioma.	NCAM1 KLRK1	1.95e-05	2	154	2	33122818
Pubmed	Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction.	RYR1 RYR3	1.95e-05	2	154	2	15894801
Pubmed	AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells.	AKR1D1 NR3C1	1.95e-05	2	154	2	30769091
Pubmed	Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor.	GFAP NF1	1.95e-05	2	154	2	9878702
Pubmed	Common allosteric mechanisms between ryanodine and inositol-1,4,5-trisphosphate receptors.	RYR1 ITPR3	1.95e-05	2	154	2	21150295
Pubmed	Effect of calmodulin on Ca2+-induced Ca2+ release of skeletal muscle from mutant mice expressing either ryanodine receptor type 1 or type 3.	RYR1 RYR3	1.95e-05	2	154	2	9817784
Pubmed	KIF1B and NF1 are the most frequently mutated genes in paraganglioma and pheochromocytoma tumors.	KIF1B NF1	1.95e-05	2	154	2	28515046
Pubmed	Analysis of DOK-6 function in downstream signaling of RET in human neuroblastoma cells.	DOK6 RET	1.95e-05	2	154	2	20210798
Pubmed	Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation.	UGT2B15 UGT2B17	1.95e-05	2	154	2	28228532
Pubmed	Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium.	UGT2B15 UGT2B17	1.95e-05	2	154	2	15666817
Pubmed	Phosphorylation of BACH1 switches its function from transcription factor to mitotic chromosome regulator and promotes its interaction with HMMR.	MYBBP1A EML4 ACTL6A MTCL1 DYNC1H1	2.14e-05	75	154	5	29459360
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	GFAP MDN1 SACS MACF1 DYNC1H1	2.29e-05	76	154	5	27542412
Pubmed	A dual function of Bcl11b/Ctip2 in hippocampal neurogenesis.	RELN DSP GFAP	2.36e-05	13	154	3	22588081
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	MYBBP1A COPA NELFCD EML4 MDN1 RACK1 PWP2 C1QBP PDCD11 PSMD14 IMMT DYNC1H1	2.95e-05	638	154	12	33239621
Pubmed	Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.	TRAPPC11 TSHZ3 HAUS6 MYBBP1A BIN1 SLF1 NRAP PLEKHF2 TMEM39B TMTC2 ACTL6A CHRM2 RASGRP3	3.18e-05	750	154	13	11230166
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	MYO1A COPA DSP CAPZB KRT23 MDN1 RACK1 C1QBP C3 PSMD14 IMMT DYNC1H1	3.37e-05	647	154	12	26618866
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ZC3H14 TBC1D30 RALGAPB ORC1 ORAI1 SLC9A1 GTF2H1 PPP2R5E MDN1 CNOT6L RACK1 ZBED6 NUFIP2 PWP2 PDCD11 MACF1 TFB2M CDC27 IMMT	3.72e-05	1497	154	19	31527615
Pubmed	IGF-I promotes neuronal migration and positioning in the olfactory bulb and the exit of neuroblasts from the subventricular zone.	RELN NCAM1 GFAP	3.73e-05	15	154	3	19712103
Pubmed	Physiological and pathophysiological characteristics of ataxin-3 isoforms.	COPA DIABLO DSP RACK1 NUFIP2 C1QBP PSMD14 DYNC1H1	3.88e-05	281	154	8	30455355
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	DNHD1 COPA ABCA13 SERPINA2 RYR1 ORC1 RACK1	4.18e-05	208	154	7	33230847
Pubmed	SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.	MYBBP1A COPA DSP RACK1 NUFIP2 C1QBP PDCD11 ZMYM1 IMMT DYNC1H1	4.42e-05	463	154	10	34901782
Pubmed	Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.	NRAP CAPZB DMD	4.57e-05	16	154	3	16717059
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	MYBBP1A COPA DSP NWD2 NF1 WASHC5 CADPS NUFIP2 C3 IMMT	5.48e-05	475	154	10	31040226
Pubmed	Identification of RanBP 9/10 as interacting partners for protein kinase C (PKC) gamma/delta and the D1 dopamine receptor: regulation of PKC-mediated receptor phosphorylation.	GFAP MACF1 DYNC1H1	5.53e-05	17	154	3	20395553
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR3	5.83e-05	3	154	2	18403125
Pubmed	Characterization and mapping of the 12 kDa FK506-binding protein (FKBP12)-binding site on different isoforms of the ryanodine receptor and of the inositol 1,4,5-trisphosphate receptor.	RYR1 RYR3	5.83e-05	3	154	2	11171121
Pubmed	Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.	UGT2B15 UGT2B17	5.83e-05	3	154	2	19572376
Cytoband	4q13	UGT2B7 UGT2B15 UGT2B17	1.64e-05	15	154	3	4q13
Cytoband	12q24.31	DIABLO MLXIP ORAI1 SBNO1	1.58e-04	80	154	4	12q24.31
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR3	1.04e-04	3	107	2	287
GeneFamily	tRNA-splicing endonuclease subunits	TSEN2 TSEN15	2.07e-04	4	107	2	776
GeneFamily	WASH complex	WASHC4 WASHC5	5.12e-04	6	107	2	1331
GeneFamily	UDP glucuronosyltransferases	UGT2B7 UGT2B15 UGT2B17	8.82e-04	32	107	3	363
GeneFamily	EF-hand domain containing\|Plakins	DSP MACF1	9.49e-04	8	107	2	939
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	DOK6 PLEKHF2 KIF1B ARHGEF18 CADPS BTK	1.42e-03	206	107	6	682
GeneFamily	ATP binding cassette subfamily A	ABCA2 ABCA13	3.01e-03	14	107	2	805
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	TSHZ3 TSHZ2	3.46e-03	15	107	2	529
GeneFamily	WD repeat domain containing\|Protein phosphatase 2 regulatory subunits	PPP2R2C PPP2R5E	3.46e-03	15	107	2	696
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	BCL2L2 RYR1 ITPR3 SLC9A1 SACS	4.44e-03	181	107	5	694
GeneFamily	Actins\|Deafness associated genes	OTOA DIABLO TECTA LOXHD1	4.56e-03	113	107	4	1152
GeneFamily	WD repeat domain containing	COPA EML4 PPP2R2C RACK1 PWP2 GNB3	4.67e-03	262	107	6	362
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN KIF1B RET PTPRN CADPS MACF1 GMPR DYNC1H1 UNC80	2.76e-08	195	154	9	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN KIF1B RET PTPRN CADPS MACF1 GMPR DYNC1H1 UNC80	2.76e-08	195	154	9	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA RELN ABCA13 NEB RYR3 LOXHD1 DMD UNC80	2.63e-07	184	154	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA RELN ABCA13 NEB RYR3 LOXHD1 DMD UNC80	2.63e-07	184	154	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OTOA RELN ABCA13 NEB RYR3 LOXHD1 DMD UNC80	2.63e-07	184	154	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	C_00\|World / shred on cell type and cluster	TSHZ2 MLXIP TSEN2 RACK1 CADPS MAFB ADGRE5	3.04e-06	179	154	7	da2dadc3266ffebd4a34ac61bfa05fddcadcde4c
ToppCell	EC-Sinusoidal_ECs\|EC / Lineage and Cell class	MRC1 ENC1 ABCC9 RACK1 BAMBI GMPR MAFB	5.00e-06	193	154	7	1291b1d3494dcb4b9309f8bff63fb662e7eca0c8
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA KIF1B NEB PTPRN CADPS GMPR UNC80	5.00e-06	193	154	7	fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCell	(4)_Endothelial_cells-(42)_EC-sinusoidal\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	MRC1 ENC1 ABCC9 RALGAPA2 RASGRP3 GMPR MAFB	5.17e-06	194	154	7	4428b472c2042f88eae028b1770767512a515b75
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	WASHC4 DSP ARHGEF18 RACK1 MTCL1 CNGA3	6.41e-06	131	154	6	a3a086ce6e69707ca6a042f3b15c130f81909acb
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	EML4 CHRNA4 KLRK1 NUFIP2 MACF1 DYNC1H1	1.24e-05	147	154	6	94998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell	Control-B_naive-1\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SLF1 WASHC4 DSP ARHGEF18 RACK1 MACF1	1.67e-05	155	154	6	0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5
ToppCell	facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 ARHGEF18 RYR1 KLRK1 ZBP1 C3	2.00e-05	160	154	6	1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MRC1 PKD1L3 MAFB GNB3 RIOK2 IMMT	2.55e-05	167	154	6	881f64db8dea3faa7588bf04d87c20924a4e5952
ToppCell	COVID-19-kidney-Lymphatic_EC\|kidney / Disease (COVID-19 only), tissue and cell type	MRC1 RELN RALGAPA2 OR52I2 RASGRP3 GNB3	2.55e-05	167	154	6	97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f
ToppCell	Bronchial_Biopsy-Immune-Mast_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	WWC3 XKR6 BBS9 RYR3 MIPOL1 CADPS	2.64e-05	168	154	6	45ccc0cb42d21f4853190e8e9ed9a54aefefe738
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HAUS6 EML4 GMPR TFB2M GNB3 EFCAB7	2.64e-05	168	154	6	ca65321259711321c175ede67bd67a47aad81d7a
ToppCell	390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|390C / Donor, Lineage, Cell class and subclass (all cells)	EML4 ST3GAL3 XKR6 NR3C1 CNOT6L ARHGEF39	2.73e-05	169	154	6	cfc9ff103d13a2d5eacc457e800f53fdd29f7738
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NCAM1 RET PTPRN CADPS BAMBI UNC80	2.73e-05	169	154	6	b6b5bb6408c1305a00719e1b88a5e1202081faf3
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Gfra2_(Zona_Incerta,_ventral_part_(ZIV))-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	MYO1A ORC1 ATP6V0A4 PRDM12	2.91e-05	51	154	4	734b7ba494e57a0958999581c805eb90b9bbbd5a
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Gfra2_(Zona_Incerta,_ventral_part_(ZIV))\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	MYO1A ORC1 ATP6V0A4 PRDM12	2.91e-05	51	154	4	622a588dcf6f70c5e6b7133678c00fc68d70d6b5
ToppCell	Control-B_naive-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SLF1 WASHC4 DSP ARHGEF18 RACK1 MACF1	2.91e-05	171	154	6	d18855b24aadea38fd1e4592f945cf15b85e05f1
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac\|metastatic_Lymph_Node / Location, Cell class and cell subclass	DNHD1 TSHZ3 PDK4 KIF1B NEB C3	3.01e-05	172	154	6	f673a2e697b46e7cfa4186cb3fb2b98e3c83703e
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AZI2 NR3C1 ZBED6 NUFIP2 MACF1 DMD	3.42e-05	176	154	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	EML4 ST3GAL3 XKR6 NR3C1 CNOT6L ARHGEF39	3.42e-05	176	154	6	437cfc5e06416bb0fc76d1f9dc106f74e279e880
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DSP NEB PTPRN CADPS UGT2B7 CNGA3	3.53e-05	177	154	6	8dbef0005095c01a806d8c7f723dc48a4650efec
ToppCell	droplet-Kidney-KIDNEY-1m-Lymphocytic-T_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF18 NEB KLRK1 SACS IKBKE BAMBI	3.53e-05	177	154	6	36da06ca9577cdb7c7b5114e604f6546b9765c08
ToppCell	wk_20-22-Hematologic-Meg-ery-Platelet\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PLEKHF2 RIOK3 RYR3 BTK GMPR MTCL1	4.00e-05	181	154	6	724efbc200e8388829bc7d81830c2689a95fa838
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TSHZ2 CHRM2 RYR3 GMPR ADGRE5	4.13e-05	182	154	6	d3a037268f026eb2f84428b1821022503cef7756
ToppCell	B_cells-ISG-high_B_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	DSP TDRD7 ZBP1 RASGRP3 BTK GMPR	4.25e-05	183	154	6	dc2b00e920efa1dcc2a6265cd1024e3249c9974f
ToppCell	COVID-19-Heart-CM_4\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRAP PDK4 NCAM1 CADPS RASGRP3 DMD	4.25e-05	183	154	6	2902b6e8aa9a6f62bc1a792c971ab7f651a8e676
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRAP PDK4 NCAM1 CHRM2 CADPS DMD	4.52e-05	185	154	6	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDK4 AKR1D1 NCAM1 MDN1 SACS DMD	4.80e-05	187	154	6	69b47f00598d647e2a99427ebddf42c339428e47
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	EML4 NF1 ZBED6 NUFIP2 MACF1 DYNC1H1	4.94e-05	188	154	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-5\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DSP PLEKHF2 RACK1 RASGRP3 BTK UGT2B17	5.09e-05	189	154	6	b4237437452f86e745b91285980c48a02a95f4c6
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RET NEB PKD1L3 PTPRN CADPS UNC80	5.24e-05	190	154	6	40d8b3403f4e38436b961cd3a2e69826cbae3042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ2 ABCC9 RET MDN1 ADGRE5 DMD	5.24e-05	190	154	6	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RET NEB PKD1L3 PTPRN CADPS UNC80	5.24e-05	190	154	6	a9a705455019e28d655636de73b07540798f82e6
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RET NEB PKD1L3 PTPRN CADPS UNC80	5.24e-05	190	154	6	f6cbf6d292f488ada5f7581e1dceba6198b933d1
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ2 ABCC9 RET MDN1 ADGRE5 DMD	5.24e-05	190	154	6	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MRC1 PDK4 KIF1B RYR1 MAFB ADGRE5	5.24e-05	190	154	6	2d54fca50593fbd11fe13fc2bfaf937a05db776d
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MRC1 RELN TSHZ2 DSP NCAM1 RET	5.24e-05	190	154	6	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	COVID-19-Heart-CM_4\|Heart / Disease (COVID-19 only), tissue and cell type	NRAP PDK4 CADPS RASGRP3 CEP70 UGT2B7	5.24e-05	190	154	6	3729648a17093b438398b82e32bbccc3af7b8c5d
ToppCell	cellseq-Epithelial-Epithelial_Neuro-Secretory-PNEC-PNEC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RET NEB PTPRN CADPS BAMBI UNC80	5.40e-05	191	154	6	146cfd4daa2878536b4f381564c787919ad855a8
ToppCell	droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRAP DSP PDK4 CHRM2 RYR3 TNNI3K	5.40e-05	191	154	6	97fb4232417a39801e87725755fd16a57c250209
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	NRAP NCAM1 CHRM2 CADPS RASGRP3 DMD	5.40e-05	191	154	6	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	cellseq-Epithelial-Epithelial_Neuro-Secretory-PNEC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RET NEB PTPRN CADPS BAMBI UNC80	5.40e-05	191	154	6	12ea07565dc0e62cade9fbab4a2d763e47a341e3
ToppCell	(5)_Epi_basal\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	ENC1 CARS1 KRT23 UGT2B17 GMPR DMD	5.40e-05	191	154	6	6bda3d5a8a391d41bb4d65872492e6c094bcc4d4
ToppCell	droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRAP DSP PDK4 CHRM2 RYR3 TNNI3K	5.40e-05	191	154	6	64070a309d7e3f6001272409ab9ce206d0e7d73f
ToppCell	(11)_FOXN4+-(0)_Reference\|(11)_FOXN4+ / shred by cell type by condition	MYBBP1A PKD1L1 AKR1D1 NCAM1 ACTL6A ST3GAL3	5.55e-05	192	154	6	ef06f96b934dd05b40025f8215b6d919d3a17045
ToppCell	11.5-Airway-Epithelial-Epithelial\|Airway / Age, Tissue, Lineage and Cell class	CHRM2 PPP2R2C NWD2 PTPRN CADPS C2orf80	5.55e-05	192	154	6	a77d3692ff02ef7e066a9bd9e22725055a25c4d4
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA KIF1B NEB PTPRN GMPR UNC80	5.72e-05	193	154	6	471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCell	droplet-Pancreas-Endocrine-21m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA KIF1B NEB PTPRN GMPR UNC80	5.88e-05	194	154	6	3a3ecedcdc7691cf21775818b598208fcb980c29
ToppCell	(4)_Endothelial_cells-(42)_EC-sinusoidal\|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	MRC1 ENC1 ABCC9 RALGAPA2 GMPR MAFB	5.88e-05	194	154	6	4199900d16623eca02d674d5ada7f0989e47955e
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	NRAP NCAM1 CHRM2 CADPS RASGRP3 DMD	5.88e-05	194	154	6	c3535f7cc0076653c72db582047cff053c322397
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA KIF1B NEB PTPRN GMPR UNC80	5.88e-05	194	154	6	0b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell	18-Airway-Epithelial-Epithelial\|Airway / Age, Tissue, Lineage and Cell class	NCAM1 RET CHRM2 NWD2 PTPRN CADPS	5.88e-05	194	154	6	d3c90e1f1228f8ba0ba56105c6cf4f302c388f28
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 TSHZ2 ABCC9 NCAM1 LOXHD1 ADGRE5	6.05e-05	195	154	6	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	NRAP PDK4 NCAM1 CHRM2 UGT2B7 DMD	6.05e-05	195	154	6	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 TSHZ2 ABCC9 NCAM1 LOXHD1 ADGRE5	6.05e-05	195	154	6	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	NRAP PDK4 NCAM1 CHRM2 CADPS DMD	6.05e-05	195	154	6	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 TSHZ2 ABCC9 NCAM1 LOXHD1 ADGRE5	6.23e-05	196	154	6	a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 TSHZ2 ABCC9 NCAM1 ADGRE5 DMD	6.23e-05	196	154	6	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 TSHZ2 ABCC9 NCAM1 ADGRE5 DMD	6.23e-05	196	154	6	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 TSHZ2 ABCC9 NCAM1 LOXHD1 ADGRE5	6.23e-05	196	154	6	3e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RYR3 TNNI3K CADPS BTK GMPR MTCL1	6.40e-05	197	154	6	bed8a9b73af5caee51b1232b31c24a59353658df
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 TSHZ2 ABCC9 NCAM1 LOXHD1 ADGRE5	6.40e-05	197	154	6	b349f8e96d61a4c296af64711e11fc44459a9413
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 TSHZ2 ABCC9 NCAM1 LOXHD1 ADGRE5	6.40e-05	197	154	6	6d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RYR3 TNNI3K CADPS BTK GMPR MTCL1	6.40e-05	197	154	6	b7d5073d44aa1e2cb83ea8d8104c5ed662665755
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 TSHZ2 ABCC9 NCAM1 LOXHD1 ADGRE5	6.40e-05	197	154	6	c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MRC1 RELN TSHZ2 PKD1L3 LOXHD1 RASGRP3	6.59e-05	198	154	6	fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MRC1 RYR1 ORAI1 MAFB ADGRE5 C2orf80	6.59e-05	198	154	6	2b724d2a36843801984d46a969d33149b76c9771
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	MELK ARHGEF39 CEP135 CEP70 ZMYM1 CDC27	6.59e-05	198	154	6	5f0964c3aa7e1dc52cbb46e754078920b65bcb88
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic\|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X	MRC1 RELN TSHZ2 DSP RASGRP3 C1QBP	6.59e-05	198	154	6	7a99c341736a4a2ac48ef8e2f7951f21a7378946
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MRC1 RELN TSHZ2 PKD1L3 LOXHD1 RASGRP3	6.59e-05	198	154	6	b3a020522e064bb61949d38e442f24026e339364
ToppCell	RV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	MYO1A PDK4 CHRM2 DMD GABRR3	6.61e-05	122	154	5	1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	TSHZ3 RELN DLGAP4 NCAM1 SACS CADPS	6.96e-05	200	154	6	c6bbd33bca86ac7a76a7ba704b3e141237d04549
ToppCell	Transverse-Dendritic_cell-cycling_DCs\|Transverse / Region, Cell class and subclass	OTOA MRC1 MELK ORC1 ARHGEF39 MAFB	6.96e-05	200	154	6	f588d8889f351c797963616a3575fa43efd46b9a
ToppCell	Transverse-(5)_Dendritic_cell-(52)_cycling_DCs\|Transverse / shred on region, Cell_type, and subtype	OTOA MRC1 MELK ORC1 ARHGEF39 MAFB	6.96e-05	200	154	6	51e643d48b5e97a0e117b578a6ea7d429c6cdd1e
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_activate-7\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	OTOA DSP RASGRP3 RAB15 DMD	1.18e-04	138	154	5	76be06136c83c167cedece7515228ed4d29dd1f0
ToppCell	Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Klk6_(Klk6)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	NRAP PKD1L1 AKR1D1 KLRK1	1.26e-04	74	154	4	a53f2e1f1044f3745a1eff5ba6275c8f1fbf3ae0
ToppCell	Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnf.Klk6_(Klk6)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	NRAP PKD1L1 AKR1D1 KLRK1	1.26e-04	74	154	4	ae547cb8bbd780b19d9c6b555c27dad932dcc753
ToppCell	PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PKD1L1 RET MELK GFAP ORC1	1.35e-04	142	154	5	e160f35b3c18e77c4107fe96db5f56227c91785e
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TSHZ3 RELN TMTC2 TNNI3K MAFB	1.59e-04	147	154	5	50e86860a94be103092c40e39a172eac92372f0d
ToppCell	LA-15._Ventricular_Cardiomyocyte_III\|LA / Chamber and Cluster_Paper	NRAP PPP2R2C ARHGEF39 UGT2B7 DMD	1.59e-04	147	154	5	8970eb6b82589f39439c61a57d999661ec8342de
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPEG CHRM2 NWD2 DMD GNB3	2.03e-04	155	154	5	cd7d95cbcad248670e531d80bb83c55e36ebc573
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TSHZ3 TMTC2 TECTA BAMBI MAFB	2.16e-04	157	154	5	a98d06cef80bfe8481b0940abce2b29675e45812
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	WASHC4 DSP ARHGEF18 RACK1 RASGRP3	2.36e-04	160	154	5	7ad065337ac802de52c15ee715f6b78a3eed0cef
ToppCell	droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIGB MELK ORC1 GPR68 EFCAB7	2.36e-04	160	154	5	8a7a73b0ee1877fe02d47f745d36ae2858b529e1
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	SPEG RYR3 SACS UGT2B7 DMD	2.43e-04	161	154	5	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCA13 TECTA NEB NWD2 UNC80	2.50e-04	162	154	5	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	COVID-mono3\|COVID / Condition, Cell_class and T cell subcluster	OTOA TBC1D30 RASGRP3 C3 UNC80	2.57e-04	163	154	5	6ab4cbcd411b40920b81162c0f4b03ea67408f52
ToppCell	COVID-mono3-\|COVID / Condition, Cell_class and T cell subcluster	OTOA TBC1D30 RASGRP3 C3 UNC80	2.57e-04	163	154	5	26661c7a3a0a449ed32d4b3b28fc2fc0b237025d
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RET PTPRN CADPS BAMBI UNC80	2.64e-04	164	154	5	be49af6335f2505065cde2cb9800e4a5516811b1
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	RET PPP2R2C PTPRN ATP6V0A4 C2orf80	2.72e-04	165	154	5	9795ce31689bc63f5a2d68725ef00b23a90c3846
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TSHZ2 PDK4 CHRM2 ARHGEF39 DMD	2.79e-04	166	154	5	94636dbc039f794c735960c3425e00bdd5523602
ToppCell	normal-na-Lymphocytic_B-B_atypical-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	ENC1 NEB KRT23 RASGRP3 ADGRE5	2.79e-04	166	154	5	30a180b67572c3f4fb3a291f271f855e1b20005e
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	NR3C1 NEB UBASH3A TDRD7 CDC27	2.87e-04	167	154	5	c0c944eae0514dc8e00d0c2892a0792e157695ec
ToppCell	Control-B_intermediate-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SLF1 WASHC4 ARHGEF18 MDN1 RACK1	2.87e-04	167	154	5	948504367ecf58144d9dd74d2ec531358fc4b309
ToppCell	facs-Heart-LA-3m-Lymphocytic-T_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PGBD1 UBASH3A KLRK1 ARHGEF39 GPR68	2.95e-04	168	154	5	24d1e0a05cda09ee3b80208d75cb2b601023f3bf
Drug	dihydropyridine	BIN1 PKD1L3 CHRM2 RYR1 RYR3 ITPR3 ORAI1 SLC9A1 DMD GNB3	7.62e-07	193	153	10	CID000104822
Drug	Clorocruoro Hem	RET SERPINA2 CHRM2 CHRNA4 RYR1 RYR3 ITPR3 MAPK6	1.86e-06	123	153	8	CID003518809
Drug	NSC692750	GFAP RYR1 RYR3	5.86e-06	6	153	3	CID000078910
Drug	lorcaserin	UGT2B7 UGT2B15 UGT2B17	5.86e-06	6	153	3	ctd:C506658
Drug	testosterone glucuronide	NR3C1 NF1 UGT2B7 UGT2B15 UGT2B17	7.91e-06	41	153	5	CID000108192
Drug	ethyl iodoacetate	PTPRN UGT2B7 UGT2B15 BAMBI GMPR	8.93e-06	42	153	5	CID000012183
Drug	[[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate	RYR1 RYR3 ITPR3	1.02e-05	7	153	3	CID009547999
Drug	Br2BAPTA	RYR1 RYR3 ITPR3	1.02e-05	7	153	3	CID003081001
Drug	ethosuximide	PKD1L3 RYR1 RYR3 ITPR3 ORAI1 ADGRE5	1.06e-05	74	153	6	CID000003291
Drug	5 alpha-dihydrotestosterone	AKR1D1 ACTL6A NR3C1 SERPINA2 BBS9 ORC1 UGT2B7 UGT2B15 UGT2B17 MAPK6 IMMT	1.23e-05	323	153	11	CID000000015
Drug	AC1MMVSM	AKR1D1 NCAM1 NR3C1 DMD	1.57e-05	23	153	4	CID003292433
Drug	Cinildipine	PKD1L3 RYR1 RYR3 ITPR3 ORAI1	3.72e-05	56	153	5	CID000002752
Drug	caged InsP3	PKD1L3 RYR1 RYR3 ITPR3	4.09e-05	29	153	4	CID000122248
Drug	manidipine	ACTL6A PKD1L3 RYR1 RYR3 ITPR3 ORAI1	4.43e-05	95	153	6	CID000004008
Drug	5'-adenylyl (beta,gamma-methylene)diphosphonate	RYR1 RYR3	4.49e-05	2	153	2	ctd:C005147
Drug	propofol	COPA CHRM2 CHRNA4 RYR1 RYR3 UGT2B7 UGT2B15 DMD	4.65e-05	191	153	8	CID000004943
Drug	R 478	RYR1 RYR3 ITPR3	4.72e-05	11	153	3	CID000084223
Drug	8-amino-cADPR	RYR1 RYR3 ITPR3	4.72e-05	11	153	3	CID003081323
Drug	nilvadipine	PKD1L3 RYR1 RYR3 ITPR3 ORAI1	5.20e-05	60	153	5	CID000004494
Drug	1,8-dinitropyrene	SLC9A1 PTPRN BTK GMPR	5.36e-05	31	153	4	CID000039185
Drug	valproate	RELN NCAM1 RET PKD1L3 RYR1 RYR3 ITPR3 UGT2B7 UGT2B15 ADGRE5 MAPK6	5.59e-05	381	153	11	CID000003121
Drug	arabinosyladenine	ZC3H14 DIABLO CARS1 NARS1 RIOK3 ABCC9 ACTL6A PKD1L3 CHRM2 RYR1 RYR3 ITPR3 NF1 NME5 C3 MAPK6	5.70e-05	762	153	16	CID000000191
Drug	nicardipine	PKD1L3 CHRM2 CHRNA4 RYR1 RYR3 ITPR3 ORAI1	5.74e-05	145	153	7	CID000004473
Drug	Dantrolene-13C3	TECTA PKD1L3 RYR1 RYR3 ITPR3 ORAI1 DMD	5.74e-05	145	153	7	CID000002951
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; HL60; HG-U133A	ZC3H14 RIOK3 ACTL6A AZI2 NR3C1 TSEN2 ORC1 PDCD11	5.78e-05	197	153	8	1363_UP
Drug	Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A	EML4 DLGAP4 MLXIP BBS9 IKBKE C3 ADGRE5 ULK2	5.99e-05	198	153	8	2286_DN
Drug	gadolinium	PKD1L3 GFAP RYR1 RYR3 ITPR3 ORAI1 NF1 SACS	6.20e-05	199	153	8	CID000023982
Drug	lercanidipine	PKD1L3 RYR1 RYR3 ITPR3 ORAI1	6.59e-05	63	153	5	CID000065866
Drug	CNS 1145	PKD1L3 RYR1 RYR3 ITPR3	6.89e-05	33	153	4	CID000190902
Drug	IHC-64	PKD1L3 RYR1 RYR3 ITPR3	6.89e-05	33	153	4	CID000162753
Drug	BAPTA	CHRM2 CHRNA4 RYR1 RYR3 ITPR3 ORAI1 SLC9A1 SACS GPR68 MAPK6	7.07e-05	324	153	10	CID000104751
Drug	Bay K 8644	PKD1L3 CHRM2 RYR1 RYR3 ITPR3 ORAI1 NF1	7.11e-05	150	153	7	CID000002303
Drug	succinylcholine	CHRM2 CHRNA4 RYR1 RYR3 DMD	7.11e-05	64	153	5	CID000005314
Drug	procaine	PKD1L3 CHRM2 CHRNA4 RYR1 RYR3 ITPR3 ORAI1	8.05e-05	153	153	7	CID000004914
Drug	NSC299933	RYR1 RYR3 ORAI1	8.10e-05	13	153	3	CID000431902
Drug	AC1NOWCJ	NARS1 UGT2B7 UGT2B15 UGT2B17	8.73e-05	35	153	4	CID005120112
Drug	gallopamil	PKD1L3 RYR1 RYR3 ITPR3 ORAI1	8.86e-05	67	153	5	CID000001234
Drug	(+/-)-Huperzine A	ABCA2 CHRM2 GFAP PSMD14	9.77e-05	36	153	4	CID000001253
Drug	AC1L2AC7	PKD1L3 RYR1 RYR3 ITPR3 ORAI1	1.02e-04	69	153	5	CID000068733
Drug	1,3-dinitropyrene	PTPRN BTK GMPR	1.28e-04	15	153	3	CID000053230
Drug	Gvapspat amide	RYR1 RYR3 ITPR3	1.28e-04	15	153	3	CID000125015
Drug	CAS 298-57-7	PKD1L3 RYR1 RYR3 ITPR3 ORAI1	1.33e-04	73	153	5	CID000002761
Drug	NSC-61590	NCAM1 NR3C1	1.34e-04	3	153	2	CID000052795
Drug	oxazepam glucuronide	UGT2B7 UGT2B15	1.34e-04	3	153	2	ctd:C026256
Drug	cis-diammineplatinum(II	RYR1 RYR3	1.34e-04	3	153	2	CID000159790
Drug	2-hydroxyheptanoic acid	RYR1 RYR3	1.34e-04	3	153	2	CID002750949
Drug	8N3-cADPR	RYR1 RYR3	1.34e-04	3	153	2	CID000127713
Drug	aminodantrolene	RYR1 RYR3	1.34e-04	3	153	2	CID009570289
Drug	maltose tetrapalmitate	NR3C1 RYR1	1.34e-04	3	153	2	CID003035236
Drug	2-hydroxycarbazole	RYR1 RYR3	1.34e-04	3	153	2	CID000093551
Drug	1,1'-diheptyl-4,4'-bipyridinium	RYR1 RYR3	1.34e-04	3	153	2	CID000080262
Drug	flubendiamide	RYR1 RYR3	1.34e-04	3	153	2	CID011193251
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR1 RYR3	1.34e-04	3	153	2	CID005748312
Drug	NAADP	RYR1 RYR3 ITPR3 IMMT	1.34e-04	39	153	4	CID000123952
Drug	N-methyl-DL-aspartic acid	RELN NCAM1 NR3C1 TECTA PKD1L3 CHRM2 GFAP CHRNA4 RYR1 RYR3 ITPR3 ORAI1 BAMBI MAPK6	1.40e-04	655	153	14	CID000004376
Drug	AC1L9GJJ	CHRM2 ITPR3 NF1 BTK	1.48e-04	40	153	4	CID000444570
Drug	Phenoxybenzamine	NCAM1 NR3C1 GFAP	1.56e-04	16	153	3	ctd:D010643
Drug	2-AF	UGT2B7 UGT2B15 UGT2B17 GMPR	1.64e-04	41	153	4	CID000005800
Disease	Myopathy, Centronuclear, Autosomal Recessive	BIN1 SPEG RYR1	5.45e-07	4	153	3	C0410204
Disease	Autosomal Recessive Centronuclear Myopathy	BIN1 SPEG RYR1 ORAI1	9.07e-07	15	153	4	C3645536
Disease	deoxycholic acid glucuronide measurement	UGT2B7 UGT2B15 UGT2B17	7.51e-06	8	153	3	EFO_0800575
Disease	Intellectual Disability	ZC3H14 PIGB ACTL6A ST3GAL3 TSEN2 NF1 SACS MACF1 TFB2M TSEN15 DYNC1H1	2.32e-05	447	153	11	C3714756
Disease	X-15492 measurement	AKR1D1 UGT2B15	2.67e-05	2	153	2	EFO_0800752
Disease	Autosomal Dominant Myotubular Myopathy	BIN1 RYR1 ORAI1	3.76e-05	13	153	3	C3661489
Disease	Centronuclear myopathy	BIN1 RYR1 ORAI1	3.76e-05	13	153	3	C0175709
Disease	X-linked centronuclear myopathy	BIN1 RYR1 ORAI1	3.76e-05	13	153	3	C0410203
Disease	Myopathy, Centronuclear, 1	BIN1 RYR1 ORAI1	3.76e-05	13	153	3	C4551952
Disease	X-19141 measurement	UGT2B7 UGT2B15 UGT2B17	3.76e-05	13	153	3	EFO_0800799
Disease	Congenital Structural Myopathy	BIN1 RYR1 ORAI1	3.76e-05	13	153	3	C0752282
Disease	Myopathy, Centronuclear, Autosomal Dominant	BIN1 RYR1 ORAI1	4.77e-05	14	153	3	C1834558
Disease	Tubular Aggregate Myopathy	BIN1 RYR1 ORAI1	4.77e-05	14	153	3	C0410207
Disease	Nonsyndromic Deafness	OTOA DIABLO TMTC2 TECTA LOXHD1	6.55e-05	81	153	5	C3711374
Disease	Pheochromocytoma, Extra-Adrenal	KIF1B RET NF1	7.29e-05	16	153	3	C1257877
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR3	7.99e-05	3	153	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR3	7.99e-05	3	153	2	DOID:8545 (implicated_via_orthology)
Disease	cholic acid glucuronide measurement	UGT2B15 UGT2B17	7.99e-05	3	153	2	EFO_0800574
Disease	Congenital Fiber Type Disproportion	BIN1 RYR1 ORAI1	1.05e-04	18	153	3	C0546264
Disease	etiocholanolone glucuronide measurement	AKR1D1 UGT2B15 UGT2B17	1.25e-04	19	153	3	EFO_0800362
Disease	Pheochromocytoma	KIF1B RET NF1	1.25e-04	19	153	3	C0031511
Disease	X-25937 measurement	UGT2B15 UGT2B17	1.59e-04	4	153	2	EFO_0800937
Disease	Pontocerebellar Hypoplasia Type 2	TSEN2 TSEN15	1.59e-04	4	153	2	C2932714
Disease	X-17340 measurement	AKR1D1 UGT2B15	1.59e-04	4	153	2	EFO_0800773
Disease	hearing impairment	OTOA MYO1A DIABLO TECTA LOXHD1	1.62e-04	98	153	5	C1384666
Disease	X-24947 measurement	UGT2B7 UGT2B15 UGT2B17	1.96e-04	22	153	3	EFO_0800910
Disease	Hereditary Paraganglioma-Pheochromocytoma Syndrome	KIF1B RET NF1	2.24e-04	23	153	3	C1708353
Disease	blood strontium measurement	GNPDA1 PPP2R2C MTCL1	3.65e-04	27	153	3	EFO_0021531
Disease	Mental Depression	RELN NCAM1 NR3C1 CHRM2 GFAP CHRNA4 GNB3	3.76e-04	254	153	7	C0011570
Disease	Pontocerebellar hypoplasia type 2	TSEN2 TSEN15	3.95e-04	6	153	2	cv:C2932714
Disease	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	NEB RYR1	3.95e-04	6	153	2	C1854678
Disease	Microcephaly	CARS1 TSEN2 ORC1 DYNC1H1	4.13e-04	67	153	4	C0025958
Disease	X-24574 measurement	UGT2B15 UGT2B17	5.51e-04	7	153	2	EFO_0800897
Disease	Severe Congenital Microcephaly	TSEN2 ORC1 DYNC1H1	5.52e-04	31	153	3	C3853041
Disease	pain	PGBD1 NCAM1 PKD1L3 MIPOL1 NUFIP2 MACF1	5.72e-04	196	153	6	EFO_0003843
Disease	Microlissencephaly	TSEN2 ORC1 DYNC1H1	6.65e-04	33	153	3	C1956147
Disease	Nonsyndromic genetic hearing loss	OTOA DIABLO TECTA LOXHD1	6.67e-04	76	153	4	cv:C5680182
Disease	FEV/FEC ratio	TSHZ3 WWC3 DSP EML4 SPEG KIF1B CAPZB ARHGEF18 NCAM1 NR3C1 NEB TSEN2 CADPS RASGRP3 MAFB MTCL1	6.68e-04	1228	153	16	EFO_0004713
Disease	Depressive disorder	RELN NCAM1 NR3C1 CHRM2 GFAP CHRNA4 GNB3	8.07e-04	289	153	7	C0011581
Disease	Bipolar Disorder	RELN ABCA13 NCAM1 NR3C1 CHRM2 GFAP PPP2R2C RACK1 GNB3	8.96e-04	477	153	9	C0005586
Disease	plasma clozapine-to-N-desmethylclozapine ratio measurement	UGT2B7 UGT2B15	9.39e-04	9	153	2	EFO_0600040
Disease	X-12844 measurement	AKR1D1 UGT2B15	9.39e-04	9	153	2	EFO_0021339
Disease	testosterone measurement	HAUS6 TSHZ2 EML4 DLGAP4 AKR1D1 SNUPN NR3C1 SERPINA2 NF1 NUFIP2 CEP70 UGT2B7 UGT2B15 UGT2B17 MACF1 MAFB	9.93e-04	1275	153	16	EFO_0004908
Disease	Seizures	PIGB GFAP CHRNA4 MACF1 GNB3 TSEN15	9.95e-04	218	153	6	C0036572
Disease	4-androsten-3alpha,17alpha-diol monosulfate (3) measurement	UGT2B15 UGT2B17	1.17e-03	10	153	2	EFO_0022090
Disease	3-methyl-2-oxobutyrate measurement	NR3C1 ANKRD50	1.17e-03	10	153	2	EFO_0021020
Disease	Immature Reticulocyte Fraction Measurement	RIOK3 GMPR	1.17e-03	10	153	2	EFO_0009253
Disease	fear of medical pain measurement	WWC3 TNNI3K	1.17e-03	10	153	2	EFO_0008339
Disease	osteoarthritis, knee, body mass index	PKD1L3 MAFB MAPK6	1.26e-03	41	153	3	EFO_0004340, EFO_0004616
Disease	DNA repair protein RAD51 homolog 4 measurement	UGT2B15 UGT2B17	1.42e-03	11	153	2	EFO_0801531
Disease	level of Sterol ester (27:1/20:5) in blood serum	CPT1A NWD2	1.42e-03	11	153	2	OBA_2045197
Disease	response to virus	BBS9 MAFB	1.42e-03	11	153	2	GO_0009615
Disease	osteoarthritis, knee	SNUPN XKR6 ITPR3 SBNO1 MAPK6	1.43e-03	158	153	5	EFO_0004616
Disease	dilated cardiomyopathy (is_implicated_in)	DSP ABCC9 DMD	1.45e-03	43	153	3	DOID:12930 (is_implicated_in)
Disease	survival time, lung adenocarcinoma	CAPZB NWD2	1.70e-03	12	153	2	EFO_0000571, EFO_0000714
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ITPR3 PPP2R2C	1.70e-03	12	153	2	DOID:1441 (implicated_via_orthology)
Disease	Congenital myopathy (disorder)	NEB RYR1	1.70e-03	12	153	2	C0270960
Disease	5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement	UGT2B15 UGT2B17	1.70e-03	12	153	2	EFO_0800291
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	XKR6 CPT1A UGT2B15 UGT2B17 MACF1 MAFB	1.73e-03	243	153	6	EFO_0004612, EFO_0020944
Disease	Major Depressive Disorder	RELN NCAM1 NR3C1 GFAP IKBKE GNB3	1.73e-03	243	153	6	C1269683
Disease	Mood Disorders	RELN NCAM1 NR3C1 CHRM2 GNB3	1.87e-03	168	153	5	C0525045
Disease	amyotrophic lateral sclerosis (biomarker_via_orthology)	KIF1B C3	2.01e-03	13	153	2	DOID:332 (biomarker_via_orthology)
Disease	cerotoylcarnitine (C26) measurement	ST3GAL3 CPT1A	2.01e-03	13	153	2	EFO_0800542
Disease	androstenediol (3alpha, 17alpha) monosulfate (3) measurement	UGT2B15 UGT2B17	2.01e-03	13	153	2	EFO_0800293
Disease	total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement	CPT1A NF1 UGT2B15	2.11e-03	49	153	3	EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612
Disease	5alpha-androstan-3alpha,17alpha-diol monosulfate measurement	UGT2B15 UGT2B17	2.33e-03	14	153	2	EFO_0800283
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	OTOA TECTA LOXHD1	2.37e-03	51	153	3	cv:CN043650
Disease	Unipolar Depression	RELN NCAM1 NR3C1 GFAP IKBKE GNB3	2.38e-03	259	153	6	C0041696
Disease	Streptozotocin Diabetes	PDK4 CPT1A CHRM2 SLC9A1	2.45e-03	108	153	4	C0038433
Disease	Diabetes Mellitus, Experimental	PDK4 CPT1A CHRM2 SLC9A1	2.45e-03	108	153	4	C0011853
Disease	Alloxan Diabetes	PDK4 CPT1A CHRM2 SLC9A1	2.45e-03	108	153	4	C0002152
Disease	alkaline phosphatase measurement	ST3GAL3 XKR6 CPT1A PKD1L3 ZBP1 NWD2 NF1 NUFIP2 UGT2B7 UGT2B15 UGT2B17 MACF1 MAFB	2.49e-03	1015	153	13	EFO_0004533
Disease	depressive disorder (biomarker_via_orthology)	NCAM1 NR3C1 CHRM2	2.51e-03	52	153	3	DOID:1596 (biomarker_via_orthology)
Disease	Alcoholic Intoxication, Chronic	CARS1 NCAM1 CHRM2 GFAP CHRNA4 RACK1	2.82e-03	268	153	6	C0001973
Disease	factor VII activating protease measurement	NRAP MELK USP32	2.94e-03	55	153	3	EFO_0009368
Disease	Pontoneocerebellar hypoplasia	TSEN2 TSEN15	3.06e-03	16	153	2	cv:C1261175
Disease	trait in response to apixaban	NELFCD NR3C1 C3 DMD	3.08e-03	115	153	4	OBA_2050328
Disease	chronic obstructive pulmonary disease	TSHZ3 DSP EML4 SPEG KIF1B CAPZB CHRNA4 RASGRP3 MAFB MTCL1	3.24e-03	688	153	10	EFO_0000341
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	XKR6 CPT1A UGT2B15 UGT2B17 MACF1 MAFB	3.26e-03	276	153	6	EFO_0004612, EFO_0020943
Disease	omega-3 polyunsaturated fatty acid measurement	CPT1A UGT2B15 UGT2B17 MAFB	3.37e-03	118	153	4	EFO_0010119
Disease	Huntington Disease	RELN DIABLO	3.45e-03	17	153	2	C0020179
Disease	major depressive disorder (is_implicated_in)	NR3C1 CHRM2	3.45e-03	17	153	2	DOID:1470 (is_implicated_in)
Disease	lupus nephritis (is_marker_for)	NR3C1 C3	3.45e-03	17	153	2	DOID:0080162 (is_marker_for)
Disease	Charcot-Marie-Tooth disease type 2	KIF1B DYNC1H1	3.45e-03	17	153	2	cv:C0270914
Disease	Sjogren syndrome	ATG5 RELN RASGRP3	3.77e-03	60	153	3	EFO_0000699
Disease	5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement	UGT2B15 UGT2B17	3.87e-03	18	153	2	EFO_0800288
Disease	bipolar disorder (is_marker_for)	RELN CHRM2	4.31e-03	19	153	2	DOID:3312 (is_marker_for)
Disease	COVID-19 (is_marker_for)	GFAP BTK C3	4.32e-03	63	153	3	DOID:0080600 (is_marker_for)
Disease	androsterone glucuronide measurement	UGT2B15 UGT2B17	4.77e-03	20	153	2	EFO_0800317

Protein segments in the cluster

Peptide	Gene	Start	Entry
IMFSSLYRISKEHWN	PPP2R5E	386	Q16537
KLSISSDNMQHAYWE	AZI2	211	Q9H6S1
SWTYDKAKIDLVNMH	CHRNA4	181	P43681
ETYMSADDLRINLWH	PPP2R2C	186	Q9Y2T4
IYTSSKEDRNAWMAH	ARHGEF18	766	Q6ZSZ5
MAHYDLAISVALQWL	C2orf80	41	Q0P641
LNTDSLDWALYDHLM	C1QBP	226	Q07021
WYSKHMTRSQAEQLL	BTK	281	Q06187
LYHKSNLCATWEAME	AKR1D1	141	P51857
SALKYHLQMLAAENW	ARMH2	196	H3BNL8
KLETMYNHWTWELRS	GVINP1	1746	Q7Z2Y8
WDSFQAILDHTYKMH	ACTL6A	96	O96019
LMAHYDVEDWKLTLI	ADGRE5	536	P48960
LEEKKHYLMWGLSSD	C3	1596	P01024
VAHLWEYVMSIDSLQ	CPT1A	481	P50416
QHLYMLAKSLEETWS	ABCA13	3036	Q86UQ4
MVAYLETQLADWIHS	BCL2L2	126	Q92843
HKLQYLTHADWIIAM	ABCC9	871	O60706
IMTVLYWHISRASKS	CHRM2	201	P08172
ITELYHAVWTKNMSL	ANKRD50	366	Q9ULJ7
KHQEYLKLETTWMTA	DIABLO	146	Q9NR28
TCWDHPKMTELYQSL	DMD	3081	P11532
TLSQAMYEGHWLVLD	DNHD1	4141	Q96M86
MLETPLQWLSEHLSY	ATG5	246	Q9H1Y0
HYKLTSTVMLWLQTN	CAPZB	166	P47756
SMKFDELYHLKANSW	DLGAP4	896	Q9Y2H0
LMSTDQEELSRWYHS	ARHGEF39	311	Q8N4T4
IMVTSDDKSSQYVWH	NWD2	1371	Q9ULI1
SSERSYQHIMKWVSD	RAB15	91	P59190
VLSSYWSQHLGKKEM	PBLD	236	P30039
AMLWDLNEGKHLYTL	RACK1	216	P63244
YALRWKELEMHSLAL	MTCL1	996	Q9Y4B5
VEMKEIYTSNHIWTL	ITPR3	1426	Q14573
MEDLISLWQYDHLTA	MELK	301	Q14680
WYIQSLMDLVEFHEK	PDK4	91	Q16654
HYQWSALVKMSENEL	RAD9B	61	Q6WBX8
DKTSAHSQRALYSWM	OTOA	221	Q7RTW8
TWLTDRMDLQLHIYQ	CADPS	1271	Q9ULU8
SWHDDLTQYVISQEM	PTPRN	96	Q16849
TEKSTKHWFSIYQML	MDN1	3831	Q9NU22
TEQKTHLEDLYWMAS	MAFB	76	Q9Y5Q3
PMSVEHADIWVKSYS	IL15RA	36	Q13261
LEQMIAHTTWRDLFY	NELFCD	146	Q8IXH7
MKLIILEHYSQASEW	GNPDA1	1	P46926
LHEYTVLPEDMKTQW	NRAP	656	Q86VF7
MENWSKDITHSYLEQ	MIPOL1	1	Q8TD10
HYQLMRKSQILISSW	MYO1A	716	Q9UBC5
SMSKYDLLVWFEISE	KIF1B	1246	O60333
MQSTANYLWHTDDLL	IKBKE	1	Q14164
LAWHVKTITITEMEY	LOXHD1	1891	Q8IVV2
LNEHSMQALSWRKLY	ORAI1	66	Q96D31
ILLMDETHSHIYNWE	MAPK6	341	Q16659
EDQDLLKLVKSYHWM	KLRK1	141	P26718
AMILARHKAISYWLE	NME5	81	P56597
HRDLDTWYKEQSAAM	KRT23	256	Q9C075
FWYDMAALLTTIKDT	MACF1	2136	O94854
AHQLWLSVEALKYSM	IMMT	566	Q16891
AKIYAMHWATDSKLL	GNB3	56	P16520
NLHLDDQMTLLQYSW	NR3C1	586	P04150
DASQEDHRSWMTYIK	PRDM12	151	Q9H4Q4
ASSNMHEAEEWYRSK	GFAP	246	P14136
LVSYWEKLQMFETSL	RALGAPA2	1211	Q2PPJ7
MLHIYQDVTLKWATQ	BBS9	311	Q3SYG4
AEKFWYDMAALLTTI	MACF1	6006	Q9UPN3
TGSSRLHDLYWQAMK	MYBBP1A	1126	Q9BQG0
LQYSHDAGMSWFLVK	RELN	1321	P78509
ELDLLWTHKQDIMYN	ORC1	621	Q13415
LSSLVQDDDMLYWHK	MLXIP	241	Q9HAP2
HKYITEVSRWESLMA	CEP135	856	Q66GS9
MWQLEEKLTYSHLEN	SERPINA2	286	P20848
DLMLYWKHGNKSLNT	GABRR3	211	A8MPY1
QMTHDGYLKLWQLSK	FBH1	621	Q8NFZ0
MDRHSSYIFIWLQLE	BAMBI	1	Q13145
IEMWADQLTSLKDLY	CEP70	396	Q8NHQ1
TMQITHENIYLWDIH	DOK6	156	Q6PKX4
DLWVTLHSMGYNKAL	EFCAB7	481	A8K855
VKYVIWSADMSHVAL	COPA	491	P53621
SLVSWHYCMIDIEKI	DSP	546	P15924
VEEHLWFYSRLKSMA	ABCA2	1081	Q9BZC7
GLMLDSHEELYKWFT	DYNC1H1	3041	Q14204
VTAFEKEHLWMYLQA	HAUS6	6	Q7Z4H7
YDTLHEEWSKAAPML	ENC1	361	O14682
HLDWSPDNKYIMSNS	EML4	726	Q9HC35
SMFTAIHKHYSLDDW	GMPR	71	P36959
WMDYHQKLVDQALLT	BIN1	111	O00499
TRQTWLLLHMYDSDK	C7orf50	121	Q9BRJ6
MVWKNLYIHFSEDLT	SACS	781	Q9NZJ4
KVVSDDALMHWLDQY	SBNO1	1256	A3KN83
NMFLESYKAAWILTE	RYR1	3651	P21817
MEIYSTTLWHLQKDV	CDC27	536	P30260
LWVEVYANHVLLMSD	PKD1L1	51	Q8TDX9
HIWLQSLAYCMKLEE	KIF28P	641	B7ZC32
VYAATATEKSEWMNH	PLEKHF2	111	Q9H8W4
HKKSWMEGLTLQDYS	PSMD14	221	O00487
WAKELLTSIYFLMHE	GPR68	146	Q15743
TKQLLEGIWSYLMHF	OR52I1	301	Q8NGK6
QSSHLWLAISLSAMY	OR52I2	51	Q8NH67
SYSLMRQKFQWHEAE	MRC1	1106	P22897
LWTLLVYSMLSHKEF	PIGB	346	Q92521
SKRYQHSVEWAAELM	TSEN2	101	Q8NCE0
VQKLDHWLMSNSSEL	PSAPL1	301	Q6NUJ1
LAFLMHSWKDTLDYS	CARS1	431	P49589
HSWKDTLDYSSNTME	CARS1	436	P49589
MNYSDAIVWLKEHDV	NARS1	391	O43776
MHRWYLSSTELAEKL	RASGRP3	41	Q8IV61
TYSVFKIHWLMAALA	GPR108	286	Q9NPR9
SMIVEKFTQDYLWLS	PKD1L3	876	Q7Z443
YETVRMAAIKESWTH	ST3GAL3	336	Q11203
KVLHMEPWSSFDIYT	TFB2M	261	Q9H5Q4
KHYANQLMLSEWLID	SNUPN	96	O95149
TWIHDFMSEYLIELS	TDRD7	1081	Q8NHU6
DLWARMHISSLEYAA	PGBD1	321	Q96JS3
AEMLTLHNWLSFYEK	CYB5D2	111	Q8WUJ1
LMVSDTNRLWQHYKT	CNGA3	231	Q16281
MHWDPEYSDVKLIQT	CNOT6L	361	Q96LI5
SDHVMLKSLDWNAEY	NCAM1	666	P13591
TLVHADLSEYNMLWH	RIOK3	401	O14730
THIMYKNTLWIESAN	TECTA	1866	O75443
DVWSVYIDMTIKHGS	PDCD11	1796	Q14690
EEMLQTAYNKLHTWQ	GTF2H1	526	P32780
TSLMSLAWVLASYHK	XKR6	326	Q5GH73
WYDMKTHQEVTSSRL	WASHC5	846	Q12768
SQSTHYFLMDKRWNL	UNC80	2036	Q8N2C7
HYIISWKRTSAMENI	TRAPPC11	981	Q7Z392
HLLDMDEQSKAWTIY	ZBP1	151	Q9H171
AIVYHTKEMESIWNL	NUFIP2	661	Q7Z417
IMWYKDEVLLTESSH	SPEG	1516	Q15772
SLVSWLSSIDMKYHI	RYR3	4596	Q15413
LDDLSKLCSWNHYNM	PWP2	856	Q15269
LSKLPEAEHWYMESL	TMTC2	656	Q8N394
EAEHWYMESLRSKTD	TMTC2	661	Q8N394
EYSVLLFHTEMRWLS	ZBED8	321	Q8IZ13
HLLYQLLWNMFSKEV	NF1	1251	P21359
HTTIKYFLKMWSSVS	SLC9A1	376	P19634
YLHSIAIDWDKTMRF	TBC1D30	266	Q9Y2I9
MYSEWRSLHLVIQND	RALGAPB	1	Q86X10
LSMTTISHWLANVKY	TSHZ2	891	Q9NRE2
HNVSWLYLSRLSAMK	RIOK2	146	Q9BVS4
NMLLEWTIYSHKEKF	SLF1	591	Q9BQI6
LSMTTISHWLANVKY	TSHZ3	941	Q63HK5
KWMAIESLFDHIYTT	RET	916	P07949
SLYSVLKIWHIDNQM	ZNF630	111	Q2M218
IMSQHYDAKADLWSI	ULK2	186	Q8IYT8
TWNTHVMEESLYLQL	ATP6V0A4	491	Q9HBG4
KQDETGHWISTFYML	ZBED6	641	P86452
IIDNHITLKDHWTMY	WASHC4	206	Q2M389
SEMHLKSLEFWREYQ	ZMYM1	516	Q5SVZ6
TEYSHWINMKTILEE	UGT2B15	31	P54855
AEYSHWMNIKTILDE	UGT2B7	31	P16662
LMWAYEKGHDAIVTL	TNNI3K	386	Q59H18
IHAAKQLDMQSSWVY	ZC3H14	241	Q6PJT7
EILTFSKEHYNIWMV	SLC36A4	436	Q6YBV0
VYLDLMESKSWHEVN	TSEN15	66	Q8WW01
MGHLTLEDYQIWSVK	USP32	331	Q8NFA0
DYDSLSEMQLRWHSV	WWC3	711	Q9ULE0
TEYSHWINMKTILEE	UGT2B17	31	O75795
QLYSLMSSEKWHQTI	TMEM39B	436	Q9GZU3
ESDTWVKHRMYTFSL	UBASH3A	341	P57075
ITMNHRLYTEAWDKD	NEB	2716	P20929
NALTMSKHLYTEAWD	NEB	3686	P20929